Smith & Nephew (SNN) Deferred Taxes (2012 - 2013)

Smith & Nephew (SNN) posted quarterly Deferred Taxes of $3.1 billion for Q4 2013, up 48.8% year-on-year from $2.1 billion in Q4 2012, and up 48.8% on a QoQ basis from $2.1 billion in Q4 2012.

Smith & Nephew (SNN) Deferred Taxes (2012 - 2013) Analysis & Trends

Smith & Nephew (SNN) has reported Deferred Taxes for 2 consecutive years, with $3.1 billion the latest figure, recorded in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -33.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -8.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -351.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -9.40 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 7.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 51.51 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn -16.70 Mn

Historic Data

Download Data
DateValue
Dec 31, 2013 3.10 Bn
Dec 31, 2012 2.09 Bn